• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经元多巴胺D3受体:对临床前研究和中枢神经系统疾病的转化意义

Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders.

作者信息

Kiss Béla, Laszlovszky István, Krámos Balázs, Visegrády András, Bobok Amrita, Lévay György, Lendvai Balázs, Román Viktor

机构信息

Pharmacological and Drug Safety Research, Gedeon Richter Plc., 1103 Budapest, Hungary.

Medical Division, Gedeon Richter Plc., 1103 Budapest, Hungary.

出版信息

Biomolecules. 2021 Jan 14;11(1):104. doi: 10.3390/biom11010104.

DOI:10.3390/biom11010104
PMID:33466844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7830622/
Abstract

Dopamine (DA), as one of the major neurotransmitters in the central nervous system (CNS) and periphery, exerts its actions through five types of receptors which belong to two major subfamilies such as D1-like (i.e., D1 and D5 receptors) and D2-like (i.e., D2, D3 and D4) receptors. Dopamine D3 receptor (D3R) was cloned 30 years ago, and its distribution in the CNS and in the periphery, molecular structure, cellular signaling mechanisms have been largely explored. Involvement of D3Rs has been recognized in several CNS functions such as movement control, cognition, learning, reward, emotional regulation and social behavior. D3Rs have become a promising target of drug research and great efforts have been made to obtain high affinity ligands (selective agonists, partial agonists and antagonists) in order to elucidate D3R functions. There has been a strong drive behind the efforts to find drug-like compounds with high affinity and selectivity and various functionality for D3Rs in the hope that they would have potential treatment options in CNS diseases such as schizophrenia, drug abuse, Parkinson's disease, depression, and restless leg syndrome. In this review, we provide an overview and update of the major aspects of research related to D3Rs: distribution in the CNS and periphery, signaling and molecular properties, the status of ligands available for D3R research (agonists, antagonists and partial agonists), behavioral functions of D3Rs, the role in neural networks, and we provide a summary on how the D3R-related drug research has been translated to human therapy.

摘要

多巴胺(DA)作为中枢神经系统(CNS)和外周的主要神经递质之一,通过属于两个主要亚家族的五种类型受体发挥作用,即D1样受体(即D1和D5受体)和D2样受体(即D2、D3和D4受体)。多巴胺D3受体(D3R)于30年前被克隆,其在中枢神经系统和外周的分布、分子结构、细胞信号传导机制已得到广泛研究。D3R参与了多种中枢神经系统功能,如运动控制、认知、学习、奖赏、情绪调节和社会行为。D3R已成为药物研究的一个有前景的靶点,人们为获得高亲和力配体(选择性激动剂、部分激动剂和拮抗剂)付出了巨大努力,以阐明D3R的功能。人们一直在大力推动寻找对D3R具有高亲和力、选择性和各种功能的类药物化合物,希望它们能为精神分裂症、药物滥用、帕金森病、抑郁症和不宁腿综合征等中枢神经系统疾病提供潜在的治疗选择。在这篇综述中,我们概述并更新了与D3R相关的主要研究方面:在中枢神经系统和外周的分布、信号传导和分子特性、可用于D3R研究的配体(激动剂、拮抗剂和部分激动剂)的现状、D3R的行为功能、在神经网络中的作用,并且我们总结了与D3R相关的药物研究如何转化为人类治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f784/7830622/5c71b65af223/biomolecules-11-00104-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f784/7830622/c71f2bd36f55/biomolecules-11-00104-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f784/7830622/61e7e10ea3b0/biomolecules-11-00104-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f784/7830622/5c71b65af223/biomolecules-11-00104-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f784/7830622/c71f2bd36f55/biomolecules-11-00104-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f784/7830622/61e7e10ea3b0/biomolecules-11-00104-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f784/7830622/5c71b65af223/biomolecules-11-00104-g003.jpg

相似文献

1
Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders.神经元多巴胺D3受体:对临床前研究和中枢神经系统疾病的转化意义
Biomolecules. 2021 Jan 14;11(1):104. doi: 10.3390/biom11010104.
2
Targeting the dopamine D3 receptor: an overview of drug design strategies.靶向多巴胺 D3 受体:药物设计策略概述。
Expert Opin Drug Discov. 2016 Jul;11(7):641-64. doi: 10.1080/17460441.2016.1185413. Epub 2016 May 30.
3
Current drug treatments targeting dopamine D3 receptor.目前针对多巴胺 D3 受体的药物治疗方法。
Pharmacol Ther. 2016 Sep;165:164-77. doi: 10.1016/j.pharmthera.2016.06.007. Epub 2016 Jun 22.
4
Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis.确定精神兴奋剂成瘾的药物靶点:揭开多巴胺 D3 受体假说。
J Med Chem. 2015 Jul 23;58(14):5361-80. doi: 10.1021/jm501512b. Epub 2015 Mar 31.
5
Selective overexpression of dopamine D3 receptors in the striatum disrupts motivation but not cognition.纹状体中多巴胺D3受体的选择性过表达会破坏动机,但不会影响认知。
Biol Psychiatry. 2014 Nov 15;76(10):823-31. doi: 10.1016/j.biopsych.2013.11.023. Epub 2013 Dec 5.
6
Using click chemistry toward novel 1,2,3-triazole-linked dopamine D3 receptor ligands.利用点击化学合成新型1,2,3-三唑连接的多巴胺D3受体配体。
Bioorg Med Chem. 2015 Jul 15;23(14):4000-12. doi: 10.1016/j.bmc.2015.01.017. Epub 2015 Jan 17.
7
Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor.新型双位点激动剂的手性决定了其在多巴胺 D3 受体上独特的药理学特性。
Biomolecules. 2021 Apr 13;11(4):570. doi: 10.3390/biom11040570.
8
Dopamine D3/D2 Receptor Antagonist PF-4363467 Attenuates Opioid Drug-Seeking Behavior without Concomitant D2 Side Effects.多巴胺 D3/D2 受体拮抗剂 PF-4363467 可减轻阿片类药物觅药行为而无 D2 受体相关副作用。
ACS Chem Neurosci. 2017 Jan 18;8(1):165-177. doi: 10.1021/acschemneuro.6b00297. Epub 2016 Oct 21.
9
Dopamine D3 Receptor Heteromerization: Implications for Neuroplasticity and Neuroprotection.多巴胺 D3 受体异源二聚化:对神经可塑性和神经保护的影响。
Biomolecules. 2020 Jul 9;10(7):1016. doi: 10.3390/biom10071016.
10
Dopamine D3 receptors modulate the rate of neuronal recovery, cell recruitment in Area X, and song tempo after neurotoxic damage in songbirds.多巴胺D3受体可调节鸣禽神经毒性损伤后神经元的恢复速度、X区的细胞募集以及鸣叫节奏。
Neuroscience. 2016 Sep 7;331:158-68. doi: 10.1016/j.neuroscience.2016.06.032. Epub 2016 Jun 23.

引用本文的文献

1
Brain Tumors, AI and Psychiatry: Predicting Tumor-Associated Psychiatric Syndromes with Machine Learning and Biomarkers.脑肿瘤、人工智能与精神病学:利用机器学习和生物标志物预测肿瘤相关精神综合征
Int J Mol Sci. 2025 Aug 22;26(17):8114. doi: 10.3390/ijms26178114.
2
Late-Onset Oral Cenesthopathy With Dopaminergic Dysfunction: Therapeutic Response to Pramipexole in a Case With Suspected Prodromal Lewy Body Disease.迟发性口腔感觉障碍伴多巴胺能功能障碍:疑似前驱性路易体病病例对普拉克索的治疗反应
Psychogeriatrics. 2025 Sep;25(5):e70088. doi: 10.1111/psyg.70088.
3
Transdiagnostic Efficacy of Cariprazine: A Systematic Review and Meta-Analysis of Efficacy Across Ten Symptom Domains.

本文引用的文献

1
Pharmacology profile of F17464, a dopamine D receptor preferential antagonist.F17464 作为一种多巴胺 D 受体选择性拮抗剂的药理学特性。
Eur J Pharmacol. 2021 Jan 5;890:173635. doi: 10.1016/j.ejphar.2020.173635. Epub 2020 Oct 14.
2
Evidence for a Stereoselective Mechanism for Bitopic Activity by Extended-Length Antagonists of the D Dopamine Receptor.延长型 D 多巴胺受体拮抗剂的双位点活性的立体选择性机制的证据。
ACS Chem Neurosci. 2020 Oct 21;11(20):3309-3320. doi: 10.1021/acschemneuro.0c00425. Epub 2020 Oct 5.
3
Association of dopamine D receptor binding potential measured using PET and [C]-(+)-PHNO with post-mortem DRD gene expression in the human brain.
卡立普嗪的跨诊断疗效:对十个症状领域疗效的系统评价和荟萃分析
Pharmaceuticals (Basel). 2025 Jul 2;18(7):995. doi: 10.3390/ph18070995.
4
[Akathisia related to antipsychotics: mirtazapine as a therapeutic option?].[抗精神病药物所致静坐不能:米氮平作为一种治疗选择?]
Nervenarzt. 2025 Sep;96(5):500-503. doi: 10.1007/s00115-025-01868-w. Epub 2025 Jul 22.
5
Blockade of Dopamine D3 Receptors in the Ventral Tegmental Area Mitigates Fear Memory Generalization.腹侧被盖区多巴胺 D3 受体的阻断减轻恐惧记忆泛化。
Int J Mol Sci. 2025 Jul 7;26(13):6520. doi: 10.3390/ijms26136520.
6
Nicotine replacement therapy: insights into the mechanisms and potential of nicotine receptor pathway.尼古丁替代疗法:对尼古丁受体途径机制及潜力的见解
Am J Transl Res. 2025 Apr 15;17(4):2396-2410. doi: 10.62347/MOBZ7773. eCollection 2025.
7
ESG-1-60 and ESG-1-61: Novel dopamine D receptor-preferring partial agonists/antagonists that inhibit cocaine taking and seeking in rodents.ESG-1-60和ESG-1-61:新型多巴胺D受体偏好性部分激动剂/拮抗剂,可抑制啮齿动物的可卡因摄取和觅药行为。
Br J Pharmacol. 2025 Jul;182(13):2997-3016. doi: 10.1111/bph.70021. Epub 2025 Mar 27.
8
Biased Signaling Agonists Promote Distinct Phosphorylation and Conformational States of the Dopamine D3 Receptor.偏倚信号激动剂促进多巴胺 D3 受体的不同磷酸化和构象状态。
Int J Mol Sci. 2024 Sep 28;25(19):10470. doi: 10.3390/ijms251910470.
9
Blockade of dopamine D3 receptors improves hippocampal synaptic function and rescues age-related cognitive phenotype.阻断多巴胺 D3 受体可改善海马突触功能并挽救与年龄相关的认知表型。
Aging Cell. 2024 Nov;23(11):e14291. doi: 10.1111/acel.14291. Epub 2024 Sep 5.
10
Linkers in Bitopic Agonists Shape Bias Profile among Transducers for the Dopamine D2 and D3 Receptors.双位激动剂中的连接体塑造多巴胺D2和D3受体转导器之间的偏向性特征。
ACS Pharmacol Transl Sci. 2024 Jul 26;7(8):2333-2349. doi: 10.1021/acsptsci.4c00119. eCollection 2024 Aug 9.
使用正电子发射断层扫描和 [C]-(+)-PHNO 测量的多巴胺 D 受体结合潜能与人类大脑死后 DRD 基因表达的关联。
Neuroimage. 2020 Dec;223:117270. doi: 10.1016/j.neuroimage.2020.117270. Epub 2020 Aug 17.
4
Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia.多巴胺受体亚型、生理学与药理学:精神分裂症中的新配体与概念
Front Pharmacol. 2020 Jul 14;11:1003. doi: 10.3389/fphar.2020.01003. eCollection 2020.
5
The Long-Acting D3 Partial Agonist MC-25-41 Attenuates Motivation for Cocaine in Sprague-Dawley Rats.长效 D3 部分激动剂 MC-25-41 可减弱 Sprague-Dawley 大鼠可卡因的觅药动机。
Biomolecules. 2020 Jul 18;10(7):1076. doi: 10.3390/biom10071076.
6
Structure of a D2 dopamine receptor-G-protein complex in a lipid membrane.D2 多巴胺受体- G 蛋白复合物在脂质膜中的结构。
Nature. 2020 Aug;584(7819):125-129. doi: 10.1038/s41586-020-2379-5. Epub 2020 Jun 11.
7
Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs.用于改善阿尔茨海默病认知和现实世界功能的双效药物:聚焦5-HT6和D3受体作为关键靶点。
Neuropharmacology. 2020 Oct 15;177:108099. doi: 10.1016/j.neuropharm.2020.108099. Epub 2020 Jun 7.
8
A novel molecular mechanism responsible for phosphorylation-independent desensitization of G protein-coupled receptors exemplified by the dopamine D receptor.一种新型分子机制负责磷酸化非依赖性的 G 蛋白偶联受体脱敏,多巴胺 D 受体就是一个很好的例子。
Biochem Biophys Res Commun. 2020 Jul 30;528(3):432-439. doi: 10.1016/j.bbrc.2020.05.197. Epub 2020 Jun 3.
9
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment.在精神分裂症的 MAM 模型中,大麻二酚治疗可逆转多巴胺 D3 受体基因表达的改变。
Biochem Pharmacol. 2020 Jul;177:114004. doi: 10.1016/j.bcp.2020.114004. Epub 2020 Apr 28.
10
Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease.[2-(3-氟-5-甲磺酰基苯氧基)乙基](丙基)胺(IRL790)的临床前药理学,一种用于治疗帕金森病运动和精神并发症的新型多巴胺传递调节剂。
J Pharmacol Exp Ther. 2020 Jul;374(1):113-125. doi: 10.1124/jpet.119.264226. Epub 2020 May 1.